Program
sildenafil
Also written as “Sildenafil”, “Sildenafil citrate” and “sildenafil citrate”.
Its studies are mostly in Erectile Dysfunction · Pulmonary Arterial Hypertension · Hypertension, Pulmonary · Sexual Dysfunctions, Psychological · Persistent Fetal Circulation Syndrome, led by 10 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Viatris | 470 open or running | phase 4since Aug 26, 2005 | Aug 26, 2005 | none ahead |
| Strategic Science & Technologies | 40 open or running | phase 2since Mar 9, 2015 | Oct 29, 2013 | none ahead |
| Hanmi Pharmaceutical | 20 open or running | phase 3since Jul 30, 2013 | Jan 18, 2012 | none ahead |
| Daré Bioscience | 10 open or running | phase 1since Mar 1, 2023 | Mar 1, 2023 | none ahead |
| emotional-brain-ny-inc | 10 open or running | phase 2since Aug 17, 2011 | Aug 17, 2011 | none ahead |
| Hamad Medical | 10 open or running | phase 3since Mar 11, 2012 | Mar 11, 2012 | none ahead |
| Hoffmann-La Roche | 10 open or running | phase 2since Oct 28, 2016 | Oct 28, 2016 | none ahead |
| laborato-rio-teuto-brasileiro-s-a | 10 open or running | phase 3since Mar 15, 2011 | Mar 15, 2011 | none ahead |
| n4-pharma-uk-ltd | 10 open or running | phase 1since Apr 12, 2018 | Apr 12, 2018 | none ahead |
| Pharmtechnology | 10 open or running | phase 1since May 6, 2021 | May 6, 2021 | none ahead |
Also a collaborator on its studies: Pfizer, bdd-pharma-ltd and icos-corporation.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 45 studies since Aug 26, 2005.
- Mar 11, 2012Hamad Medical's first study: phase 3 study in Persistent Fetal Circulation SyndromeNew to Hamad MedicalHamad Medical · NCT01558466 · 100 enrolled · Qatar
- Jun 15, 2012Phase 4 study in Pulmonary Arterial HypertensionViatris · NCT01642407 · 6 enrolled · Japan
- Aug 1, 20122 phase 1 studies in HealthyViatris · NCT01656798, NCT01737203
- Sep 17, 2012Phase 3 study in Persistent Fetal Circulation SyndromeViatris · NCT01720524 · 59 enrolled · United States, Belgium, Canada and more
- Jul 30, 2013Phase 3 study in Hypertension, PulmonaryHanmi Pharmaceutical · NCT01913847 · 144 enrolled · Korea, Republic of
- Oct 29, 2013Strategic Science & Technologies's first study: phase 1 study in HealthyNew to Strategic Science & TechnologiesStrategic Science & Technologies · NCT01986673 · 62 enrolled · United States
- Jan 29, 2014Phase 4 study in Pulmonary Arterial HypertensionViatris · NCT02060487 · 385 enrolled · United States, Australia, Belgium and more
- Jan 27, 2015Phase 1 study in Female Sexual HealthStrategic Science & Technologies · NCT02364882 · 21 enrolled · United States
- Mar 9, 2015Phase 2 study in Erectile DysfunctionStrategic Science & Technologies · NCT02390960 · 33 enrolled · United States
- Oct 28, 2016Hoffmann-La Roche's first study: phase 2 study in Idiopathic Pulmonary FibrosisNew to Hoffmann-La RocheHoffmann-La Roche · NCT02951429 · 177 enrolled · Belgium, Canada, Czechia and more
- Apr 12, 2018n4-pharma-uk-ltd's first study: phase 1 study in Erectile DysfunctionNew to n4-pharma-uk-ltdn4-pharma-uk-ltd · NCT03510338 · 12 enrolled · United Kingdom
- May 6, 2021Pharmtechnology's first study: phase 1 study in BioequivalenceNew to PharmtechnologyPharmtechnology · NCT04882826 · 44 enrolled · Russian Federation
- Jun 24, 2021Phase 2 study in Sexual Dysfunction, PhysiologicalStrategic Science & Technologies · NCT04948151 · 440 enrolled · United States
- Mar 1, 2023Daré Bioscience's first study: phase 1 study in Sexual Dysfunctions, PsychologicalNew to Daré BioscienceDaré Bioscience · NCT05765487 · 13 enrolled · Canada
TargetBeta
“Phosphodiesterase 5A inhibitor”ChEMBL 37, by rule
Other programs on PDE5A
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Tadalafilrule | Eli Lilly | phase 4 | 73 |
Studies
All 60 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT05765487Sexual Dysfunctions, Psychological · Canada | 1 | Completed | Daré Bioscience | Jan 26, 2024 | 13 |
| NCT04948151Sexual Dysfunction, Physiological · United States | 2 | UNKNOWN | Strategic Science & Technologies | Dec 15, 2021 | 440 |
| NCT04882826Bioequivalence · Russian Federation | 1 | UNKNOWN | Pharmtechnology | May 30, 2021 | 44 |
| NCT03510338Erectile Dysfunction · United Kingdom | 1 | Completed | n4-pharma-uk-ltd | Jun 13, 2018 | 12 |
| NCT02951429Idiopathic Pulmonary Fibrosis · Belgium, Canada, Czechia and more | 2 | Completed | Hoffmann-La Roche | Sep 26, 2019 | 177 |
| NCT02390960Erectile Dysfunction · United States | 2 | Completed | Strategic Science & Technologies | Apr 2017 | 33 |
| NCT02364882Female Sexual Health · United States | 1 | Completed | Strategic Science & Technologies | May 2015 | 21 |
| NCT02060487Pulmonary Arterial Hypertension · United States, Australia, Belgium and more | 4 | Terminated | Viatris | Feb 26, 2021 | 385 |
| NCT01986673Healthy · United States | 1 | Completed | Strategic Science & Technologies | Nov 2013 | 62 |
| NCT01913847Hypertension, Pulmonary · Korea, Republic of | 3 | UNKNOWN | Hanmi Pharmaceutical | Dec 2018 | 144 |
| NCT01720524Persistent Fetal Circulation Syndrome · United States, Belgium, Canada and more | 3 | Completed | Viatris | Oct 17, 2018 | 59 |
| NCT01737203Healthy · Japan | 1 | Completed | Viatris | Sep 2012 | 53 |
| NCT01656798Healthy · Singapore | 1 | Completed | Viatris | Aug 2012 | 12 |
| NCT01642407Pulmonary Arterial Hypertension · Japan | 4 | Completed | Viatris | May 20, 2016 | 6 |
| NCT01558466Persistent Fetal Circulation Syndrome · Qatar | 3 | UNKNOWN | Hamad Medical | Nov 2014 | 100 |
| NCT01514903Erectile Dysfunction · Korea, Republic of | 1 | Completed | Hanmi Pharmaceutical | Dec 2011 | 54 |
| NCT01432665Sexual Dysfunctions, Psychological · United States | 2 | Completed | emotional-brain-ny-inc | May 2013 | 196 |
| NCT01360671Persistent Fetal Circulation Syndrome | 2 | Withdrawn | Viatris | Apr 2013 | 0 |
| NCT01321489Erectile Dysfunction · Brazil | 3 | UNKNOWN | laborato-rio-teuto-brasileiro-s-a | Jan 2012 | 78 |
| NCT01247805Pulmonary Arterial Hypertention · Belgium | 1 | Completed | Viatris | Feb 2011 | 42 |
| NCT01254396Erectile Dysfunction · Singapore | 1 | Completed | Viatris | Jan 2011 | 12 |
| NCT01254383Erectile Dysfunction · Singapore | 1 | Completed | Viatris | Mar 2011 | 36 |
| NCT01027117Healthy · Belgium | 1 | Completed | Viatris | Sep 2009 | 18 |
| NCT00904748Erectile Dysfunction · Brazil | 1 | Completed | Viatris | Mar 2010 | 47 |
| NCT00866463Erectile Dysfunction · United States | 1 | Completed | Viatris | Oct 2008 | 18 |
| NCT00800592Hypertension, Pulmonary · Belgium | 1 | Completed | Viatris | Dec 2008 | 12 |
| NCT00795938Erectile Dysfunction · United States | 1 | Completed | Viatris | Nov 2008 | 18 |
| NCT00746967Sexual Dysfunctions, Psychological · United States | 2 | Completed | Viatris | 267 | |
| NCT00654082Spinal Cord Injuries · Turkey | 4 | Completed | Viatris | 88 | |
| NCT00654017Erectile Disfunction · Brazil | 4 | Completed | Viatris | 100 | |
| NCT00648596Erectile Dysfunction · Finland, France, Italy and more | 4 | Completed | Viatris | 780 | |
| NCT00644956Erectile Dysfunction · Norway, United Kingdom | 4 | Completed | Viatris | 56 | |
| NCT00644631Erectile Dysfunction · United States | 4 | Completed | Viatris | 300 | |
| NCT00645268Erectile Dysfunction · United States, Canada | 4 | Completed | Viatris | 300 | |
| NCT00645034Prostatic Hyperplasia · United States | 2 | Completed | Viatris | 20 | |
| NCT00644605Hypertension, Pulmonary · United States, Australia, Belgium and more | 3 | Completed | Viatris | 275 | |
| NCT00640458Female Sexual Arousal Disorder · United States, Australia | 2 | Completed | Viatris | 20 | |
| NCT00468650Erectile Dysfunction · Mexico | 4 | Completed | Viatris | Feb 2008 | 117 |
| NCT00454207Hypertension, Pulmonary · Japan | 3 | Completed | Viatris | Feb 2009 | 44 |
| NCT00430716Pulmonary Arterial Hypertension · United States, Belgium, Brazil and more | 4 | Terminated | Viatris | May 25, 2010 | 130 |
| NCT00343200Erectile Dysfunction · United States | 4 | Completed | Viatris | 371 | |
| NCT00323297Pulmonary Arterial Hypertension · United States, Australia, Czechia and more | 4 | Completed | Viatris | Aug 2013 | 105 |
| NCT00301262Erectile Dysfunction · Canada | 4 | Completed | Viatris | Sep 2007 | 183 |
| NCT00249730Erectile Dysfunction · Canada, France, Greece and more | 4 | Completed | Viatris | 510 | |
| NCT00245596Erectile Dysfunction · France | 4 | Completed | Viatris | 120 | |
| NCT00245258Erectile Dysfunction · Korea, Republic of, Russian Federation, Spain and more | 4 | Completed | Viatris | 312 | |
| NCT00159913Pulmonary Arterial Hypertension · United States, Brazil, Canada and more | 3 | Completed | Viatris | Jun 2008 | 235 |
| NCT00159900Erectile Dysfunction · Brazil, Germany, Italy and more | 4 | Completed | Viatris | 300 | |
| NCT00159887Hypertension, Pulmonary · United States, Australia, Belgium and more | 3 | Completed | Viatris | 260 | |
| NCT00159874Pulmonary Arterial Hypertension · United States, Brazil, Chile and more | 3 | Completed | Viatris | Dec 2012 | 234 |
| NCT00159861Hypertension, Pulmonary · United States, Belgium, Canada and more | 3 | Completed | Viatris | 267 | |
| NCT00159809Erectile Dysfunction | 4 | Completed | Viatris | 140 | |
| NCT00151463Erectile Dysfunction · Australia | 4 | Completed | Viatris | 100 | |
| NCT00150358Erectile Dysfunction · Mexico | 4 | Completed | Viatris | 253 | |
| NCT00147628Erectile Dysfunction · United States | 4 | Completed | Viatris | 209 | |
| NCT00145483Meniere Disease · Australia | 4 | Completed | Viatris | Nov 8, 2006 | 163 |
| NCT00143260Erectile Dysfunction · United States | 4 | Completed | Viatris | May 2006 | 250 |
| NCT00143221Erectile Dysfunction | 4 | Completed | Viatris | 350 | |
| NCT00141310Pre-Eclampsia · United Kingdom | 2 | Terminated | Viatris | 76 | |
| NCT00137072Erectile Dysfunction · United States | 4 | Completed | Viatris | 355 |
How it is read
Names in the registry
- “Sildenafil”, 27 entries
- “sildenafil”, 18 entries
- “Sildenafil citrate”, 14 entries
- “sildenafil citrate”, 10 entries
- “Sildenafil Citrate”, 4 entries
Conditions, from the studies’ own filings
- Erectile Dysfunction, 33 studies
- Pulmonary Arterial Hypertension, 11 studies
- Hypertension, Pulmonary, 6 studies
- Sexual Dysfunctions, Psychological, 3 studies
- Persistent Fetal Circulation Syndrome, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.